VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹716 Cr | ₹627 Cr | ₹601 Cr | ₹579 Cr | ₹556 Cr |
What is the latest Total Liabilities ratio of VENUS REMEDIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹716 Cr |
| Mar2024 | ₹627 Cr |
| Mar2023 | ₹601 Cr |
| Mar2022 | ₹579 Cr |
| Mar2021 | ₹556 Cr |
How is Total Liabilities of VENUS REMEDIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹716 Cr | 14.18 | |
| Mar2024 | ₹627 Cr | 4.28 | |
| Mar2023 | ₹601 Cr | 3.79 | |
| Mar2022 | ₹579 Cr | 4.19 | |
| Mar2021 | ₹556 Cr | - | |
Compare Total Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,295.2 Cr | -12.9% | 15.3% | 301.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -12.9% |
15.3% |
301.3% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses